RLYB - Financial Reports List - Rallybio Corporation - IntrinsicAlpha

Rallybio Corporation RLYB

Healthcare - Biotechnology - NASDAQ - US

$ 0.284

6.04 %

$ 11.8 M

Market Cap

-0.2

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	-83.33%	45.44%	45.02%
Annual Report	FY	10-K	2024-12-31	0.00%	22.52%	23.36%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	37.60%	37.69%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	12.85%	15.18%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-21.51%	-7.69%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	-24.93%	-23.53%
Annual Report	FY	10-K	2023-12-31	0.00%	-12.15%	-16.27%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	-3.21%	-2.67%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-5.95%	-14.01%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	-8.74%	-28.33%

1